Business
Press Release Jun 01 2021
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 01, 2021, titled "Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 01, 2021, titled \"Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg\". View Attachment","length":342,"tagName":"div"}]